Developer docs
API playgroundTry for free, no card

Search company profiles

Tema Sinergie

Full company profile

uuid0009vfv

Namestring
Tema Sinergie
Legal namestring
TEMA SINERGIE S.p.A.
Websiteurl
temasinergie.it
Company typeenum
Private
Founded yearint
1985
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersFaenza, Italy
HQ citystring
Faenza
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nuclear medicine equipment, radiopharmaceutical dispensing systems, barrier isolation technology, pharmaceutical isolators, radiopharmacy automation
Industry3 codes
1Radiopharmacy Compounding & Dispensing (Hospital/Commercial)
CodeHLAIAGAEPrimaryYes
2Theranostic Radiopharmaceutical Platforms (Paired Dx/Tx)
CodeHLAIAGACPrimaryNo
3Diagnostic Radiopharmaceuticals (SPECT/PET Tracers)
CodeHLAIAGAAPrimaryNo
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Nuclear Medicine and Pharmaceutical Isolation Equipment
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Hardware Sales - Radiopharmacy Equipment
TypeHardware Sales
Description

Sale of automated dispensing systems, hot cells, manipulation cells, and shielded equipment for nuclear medicine and radiopharmacy applications

temasinergie.it
2Hardware Sales - Pharmaceutical Isolation Systems
TypeHardware Sales
Description

Sale of barrier isolation systems for aseptic processing and containment applications in pharmaceutical and biotech industries

temasinergie.it
3Hardware Sales - Radiation Oncology Equipment
TypeHardware Sales
Description

Sale of products for radiation therapy and medical imaging including SpaceOAR and related technologies

temasinergie.it
4Professional Services
TypeProfessional Services
Description

Consulting during design phase, user training, commissioning and clinical start-up support, and technical assistance during and after warranty period

temasinergie.it
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels10 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1KARL100
Description

Automatic system for dispensing and infusion of PET and SPECT radiopharmaceuticals

temasinergie.it
+7 more records
Core offering1 text field

Tema Sinergie designs, manufactures, and services specialized medical and pharmaceutical equipment across four business units: (1) Radiopharma & Nuclear Medicine — automated radiopharmaceutical dispensing systems, shielded hot cells, and synthesis modules for PET/SPECT applications; (2) Pharma & ATMP — GMP-compliant barrier isolation systems for aseptic processing and containment in pharmaceutical and biotechnology manufacturing; (3) Radiation Oncology & Medical Imaging — distribution of advanced treatment devices including Sonablate HIFU for prostate ablation and SpaceOAR hydrogel; (4) Uro-Oncology — minimally invasive solutions for cancer diagnosis and treatment.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 140+ KARL100 installations worldwide
+4 more records
Product overview1 text field

Tema Sinergie is a multi-disciplinary Italian company (established 1985, 280+ employees) operating in healthcare technology across four business units: Radiopharma & Medicina Nucleare, Pharma & ATMP (Barrier Isolation Technology), Radioterapia & Medical Imaging, and Uro-Oncologia. The Radiopharma division offers a complete portfolio centered on KARL100 automatic radiopharmaceutical dispenser, complemented by µ DDS-A dose fractionation units, CRP Compact dispensers, and ASTER theranostic injector, alongside various hot cells (DHC, FLEX, NMC DSI, NMC Ga-68, TEC4) for PET/SPECT applications. The Pharma & ATMP division provides isolation systems including pharmaceutical isolators, HC-IS containment series, Aseptic Filling Isolators, AP-IS transfer isolators, and accessories like AGLTS 2 glove testing and ZEROC integrity verification. The Radiotherapy division offers Sonablate HIFU for focal prostate ablation and SpaceOAR hydrogel spacer. The company serves hospitals, research institutes, universities, and pharmaceutical industries worldwide.

Product and service15 records
1KARL100
CategoryRadiopharma & Nuclear Medicine - Automatic Dispensing Systems
Description

Automatic mobile dispensing and infusion system for PET and SPECT radiopharmaceuticals, designed to reduce operator radiation exposure in hospital nuclear medicine departments. Over 140 installations worldwide.

2µDDS-A
CategoryRadiopharma & Nuclear Medicine - Automatic Dose Drawing
Description

Compact plug-and-play automatic dose fractionation unit for PET and SPECT radiopharmaceuticals dispensed into shielded syringes. Over 225 installations worldwide, with 1.1 million syringes dispensed.

3CRP Compact / CRP Compact Plus
CategoryRadiopharma & Nuclear Medicine - Vial Dispensing
Description

Automatic radiopharmaceutical dispenser for open and closed vials with automated crimping. GMP EU Annex 1 compliant, suitable for various radiopharmaceuticals without concentration or volume limits.

4ASTER Theranostic Radiopharmaceutical Injector
CategoryRadiopharma & Nuclear Medicine - Theranostic Administration
Description

CE-certified theranostic administration system for managing the complete radiopharmaceutical infusion process from single-use vials. Minimizes operator exposure during radiometabolic therapies.

5DHC - Dispensing Hot Cell
CategoryRadiopharma & Nuclear Medicine - Shielded Hot Cells
Description

GMP Grade A shielded isolator with vertical laminar flow designed for radiopharmaceutical dispensing in a controlled and safe environment. Large internal work surface with automatic lead pot recovery system.

6FLEX Multi-Function Shielded Isolator
CategoryRadiopharma & Nuclear Medicine - Shielded Hot Cells
Description

Multi-function GMP Grade A shielded isolator with 75mm Pb shielding on all sides, configurable for various radiopharmaceutical dispensing applications and compatible with µDDS-A and CRP systems. 35 installations worldwide.

7NMC DSI Shielded Laminar Flow Isolator
CategoryRadiopharma & Nuclear Medicine - Shielded Hot Cells
Description

Shielded laminar flow isolator for manual and automatic FDG PET preparation and nuclear medicine isotope doses. GMP compliant with 100 installations worldwide.

8NMC Ga-68 Hot Cell
CategoryRadiopharma & Nuclear Medicine - Shielded Hot Cells
Description

GMP Grade A hot cell for the complete Gallium-68 cycle including elution, synthesis, and dispensing. Features 2 pre-chambers at GMP Grade B.

9Safeflow Biohazard Safety Cabinet
CategoryRadiopharma & Nuclear Medicine - Safety Cabinets
Description

Class II Biohazard Safety Cabinet with vertical laminar flow for manual preparation of injectable radiopharmaceutical doses. GMP Grade A with shielding configurations from 5 to 50mm Pb.

10VI - Visual Inspection and Labelling System
CategoryRadiopharma & Nuclear Medicine - Quality Control
Description

Automatic visual inspection and vial labelling system for nuclear medicine applications. Available in inspection-only, inspection-with-labelling, and integrated printing/labelling versions, with VPHP cycle compatibility.

11Sonablate HIFU
CategoryUro-Oncology - Focal Therapy Devices
Description

Robotic device for focal ablation of the prostate using high-intensity focused ultrasound with proprietary A³ technology (AIM, Ablate, Analyze). Distributed in Italy by Tema Sinergie for minimally invasive prostate cancer treatment.

12AseptiFill
CategoryPharma & ATMP - Aseptic Filling Systems
Description

Automatic vial filling and capping system designed for aseptic conditions, specifically for Pharma & Biotech companies producing small batches of injectable products. Integrates within Tema Sinergie isolators.

13MorGaNA Gallium-68 Labelling Device
CategoryRadiopharma & Nuclear Medicine - Generator-Based Dispensing
Description

Automatic device dedicated to Gallium-68 cold labelling and dispensing, compatible with all Gallium-68 generators. Features remote control operation and FDA 21 CFR Part 11 compliant data management. Launched January 2020.

14AGLTS 2 Automatic Glove Leak Testing System
CategoryPharma & ATMP - Isolator Accessories
Description

Automatic glove leak testing system developed for pharmaceutical isolators in response to the requirements of EU GMP Annex 1. Officially presented at Interphex in April 2023.

15ZEROC RTP Integrity Verification System
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-05-01
Description

Strategic partnership to provide solutions and post-sale services dedicated to the Chilean nuclear medicine market. Acrux provides specialized radiopharma consulting services.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-09-01
Description

ATS Elektronik is the new partner of Tema Sinergie in Turkey for the Barrier Isolation Technology business unit.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-08-01
Description

Envopack c.a. is the exclusive partner of Barrier Isolation Technology business unit for Venezuela and Dominican Republic.

4Be.Integral International Distribution
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-06-01
Description

Be.Integral International Distribution is the new technical-commercial partner in Germany for increasingly capillary presence on European territory.

temasinergie.it
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-05-07
Description

New partner for Barrier Isolation Technology for Colombia, Peru, Ecuador, Panama, and Honduras with over 35 years of activity in the pharmaceutical sector. Based in Bogota, Colombia.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-03-01
Description

STEQ America is the new partner for Barrier Isolation Technology business unit for the North American market with nearly 20 years of market experience representing world's leading manufacturers of Pharma and Biotechnology equipment.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-03-01
Description

New technical-commercial partner for Barrier Isolation Technology division for the Brazilian market with nearly 20 years of experience representing leading Pharma and Biotechnology equipment manufacturers.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-11-19
Description

Exclusive commercial agreement with LabLogic for distribution of PET and Nuclear Medicine products in the United Kingdom. LabLogic is one of the world's most respected manufacturers of instrumentation and software for Life Science, PET, Nuclear Medicine and Security sectors.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partner for Australian nuclear medicine market. Collaboration on Cyclowest nuclear medicine center project in Western Australia for FDG production.

Strategic tierCoreTypeTechnology or Integration
Description

Powered by Sonablate Corp., Tema Sinergie distributes Sonablate HIFU - a robotic device for focal ablation of prostate using high-intensity focused ultrasound with proprietary A³ technology.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership with LabLogic for customer installation support and collaboration including Royal Free London case study publication.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Italian-headquartered manufacturer of shielded cells, hot cells, and radiopharmacy equipment. Direct competitor named alongside Tema Sinergie as a top-3 global player in the radiopharmaceutical dispensing market, with overlapping product lines in PET/SPECT shielding and isolators.

TypeDirect peer
Description

Developer of focused ultrasound devices including Focal One for prostate tissue ablation. Direct peer in the uro-oncology HIFU segment where Tema Sinergie distributes Sonablate HIFU.

TypeBroad incumbent
Description

Major medical imaging and diagnostics player with PET/CT systems and growing nuclear medicine footprint. Competes indirectly through end-to-end imaging suite sales that bundle radiopharmacy workflow components.

TypeDirect peer
Description

Belgian developer of automated radiopharmaceutical synthesis and dispensing systems (e.g., AllInOne, Synthera). Named as the third top-3 player in radiopharmaceutical dispensing alongside Tema Sinergie and Comecer, with comparable PET/SPECT and Ga-68 product lines.

TypeOthers
Description

Manufacturer of Sonablate HIFU high-intensity focused ultrasound device for prostate ablation. Technology partner of Tema Sinergie rather than a direct competitor, but represents an upstream relationship that mirrors peer dynamics.

TypeBroad incumbent
Description

Global medical device and imaging giant offering PET tracers, cyclotrons, and increasingly adjacent radiopharmacy workflow solutions. As a broad incumbent, it competes at the system level and could expand into shielded-equipment categories.

TypeDirect peer
Description

Swiss manufacturer of aseptic and containment isolators for pharmaceutical and biotech manufacturing, including GMP-compliant barrier systems. Direct peer in the Pharma & ATMP / barrier isolation business unit.

TypeBroad incumbent
Description

Global bioprocessing and aseptic manufacturing equipment provider. Competes with Tema Sinergie's pharmaceutical isolation business through broader aseptic filling and containment portfolios.

TypeBroad incumbent
Description

Global provider of sterilizers, isolators, and GMP process equipment for pharmaceutical manufacturing. Competes with Tema Sinergie's Pharma & ATMP division as a broad incumbent offering integrated aseptic processing solutions.

TypeBroad incumbent
Description

World's largest nuclear medicine company, supplying SPECT/PET diagnostic tracers and therapeutic radiopharmaceuticals. Comparable as a downstream customer for shielded dispensing systems and as a potential in-house equipment competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers14 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tema Sinergie

Nuclear Medicine and Pharmaceutical Isolation Equipmenttemasinergie.it

Tema Sinergie firmographics

Firmographics
Name
Tema Sinergie
Legal name
TEMA SINERGIE S.p.A.
Website
https://temasinergie.it
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Tema Sinergie industry classification

Industry
Product category
Nuclear Medicine and Pharmaceutical Isolation Equipment
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Radiopharmacy Compounding & Dispensing (Hospital/Commercial) (HLAIAGAE)
akta.pro secondary industries
Theranostic Radiopharmaceutical Platforms (Paired Dx/Tx) (HLAIAGAC), Diagnostic Radiopharmaceuticals (SPECT/PET Tracers) (HLAIAGAA)

Keywords

  • Nuclear medicine equipment
  • Radiopharmaceutical dispensing systems
  • Barrier isolation technology
  • Pharmaceutical isolators
  • Radiopharmacy automation

Where Tema Sinergie is headquartered

Location

Headquarters

HQ city
Faenza
HQ country
Italy
HQ region
Europe

Offices2 records

Markets served

Tema Sinergie business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Hardware Sales - Radiopharmacy Equipment: Sale of automated dispensing systems, hot cells, manipulation cells, and shielded equipment for nuclear medicine and radiopharmacy applications
  2. Hardware Sales - Pharmaceutical Isolation Systems: Sale of barrier isolation systems for aseptic processing and containment applications in pharmaceutical and biotech industries
  3. Hardware Sales - Radiation Oncology Equipment: Sale of products for radiation therapy and medical imaging including SpaceOAR and related technologies
  4. Professional Services: Consulting during design phase, user training, commissioning and clinical start-up support, and technical assistance during and after warranty period

Go-to-market motion2 records

Distribution channels10 records

Marketing channels4 records

Tema Sinergie product offering

Product offering

Core offering

Tema Sinergie designs, manufactures, and services specialized medical and pharmaceutical equipment across four business units: (1) Radiopharma & Nuclear Medicine — automated radiopharmaceutical dispensing systems, shielded hot cells, and synthesis modules for PET/SPECT applications; (2) Pharma & ATMP — GMP-compliant barrier isolation systems for aseptic processing and containment in pharmaceutical and biotechnology manufacturing; (3) Radiation Oncology & Medical Imaging — distribution of advanced treatment devices including Sonablate HIFU for prostate ablation and SpaceOAR hydrogel; (4) Uro-Oncology — minimally invasive solutions for cancer diagnosis and treatment.

Product overview

Tema Sinergie is a multi-disciplinary Italian company (established 1985, 280+ employees) operating in healthcare technology across four business units: Radiopharma & Medicina Nucleare, Pharma & ATMP (Barrier Isolation Technology), Radioterapia & Medical Imaging, and Uro-Oncologia. The Radiopharma division offers a complete portfolio centered on KARL100 automatic radiopharmaceutical dispenser, complemented by µ DDS-A dose fractionation units, CRP Compact dispensers, and ASTER theranostic injector, alongside various hot cells (DHC, FLEX, NMC DSI, NMC Ga-68, TEC4) for PET/SPECT applications. The Pharma & ATMP division provides isolation systems including pharmaceutical isolators, HC-IS containment series, Aseptic Filling Isolators, AP-IS transfer isolators, and accessories like AGLTS 2 glove testing and ZEROC integrity verification. The Radiotherapy division offers Sonablate HIFU for focal prostate ablation and SpaceOAR hydrogel spacer. The company serves hospitals, research institutes, universities, and pharmaceutical industries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • KARL100: Automatic system for dispensing and infusion of PET and SPECT radiopharmaceuticals
  • VI
  • µ DDS-A
  • CRP Compact
  • ASTER
  • AseptiFill
  • AGLTS 2
  • ZEROC

Products and services

  • KARL100 Automatic mobile dispensing and infusion system for PET and SPECT radiopharmaceuticals, designed to reduce operator radiation exposure in hospital nuclear medicine departments. Over 140 installations worldwide.
  • µDDS-A Compact plug-and-play automatic dose fractionation unit for PET and SPECT radiopharmaceuticals dispensed into shielded syringes. Over 225 installations worldwide, with 1.1 million syringes dispensed.
  • CRP Compact / CRP Compact Plus Automatic radiopharmaceutical dispenser for open and closed vials with automated crimping. GMP EU Annex 1 compliant, suitable for various radiopharmaceuticals without concentration or volume limits.
  • ASTER Theranostic Radiopharmaceutical Injector CE-certified theranostic administration system for managing the complete radiopharmaceutical infusion process from single-use vials. Minimizes operator exposure during radiometabolic therapies.
  • DHC - Dispensing Hot Cell GMP Grade A shielded isolator with vertical laminar flow designed for radiopharmaceutical dispensing in a controlled and safe environment. Large internal work surface with automatic lead pot recovery system.
  • FLEX Multi-Function Shielded Isolator Multi-function GMP Grade A shielded isolator with 75mm Pb shielding on all sides, configurable for various radiopharmaceutical dispensing applications and compatible with µDDS-A and CRP systems. 35 installations worldwide.
  • NMC DSI Shielded Laminar Flow Isolator Shielded laminar flow isolator for manual and automatic FDG PET preparation and nuclear medicine isotope doses. GMP compliant with 100 installations worldwide.
  • NMC Ga-68 Hot Cell GMP Grade A hot cell for the complete Gallium-68 cycle including elution, synthesis, and dispensing. Features 2 pre-chambers at GMP Grade B.
  • Safeflow Biohazard Safety Cabinet Class II Biohazard Safety Cabinet with vertical laminar flow for manual preparation of injectable radiopharmaceutical doses. GMP Grade A with shielding configurations from 5 to 50mm Pb.
  • VI - Visual Inspection and Labelling System Automatic visual inspection and vial labelling system for nuclear medicine applications. Available in inspection-only, inspection-with-labelling, and integrated printing/labelling versions, with VPHP cycle compatibility.
  • Sonablate HIFU Robotic device for focal ablation of the prostate using high-intensity focused ultrasound with proprietary A³ technology (AIM, Ablate, Analyze). Distributed in Italy by Tema Sinergie for minimally invasive prostate cancer treatment.
  • AseptiFill Automatic vial filling and capping system designed for aseptic conditions, specifically for Pharma & Biotech companies producing small batches of injectable products. Integrates within Tema Sinergie isolators.
  • MorGaNA Gallium-68 Labelling Device Automatic device dedicated to Gallium-68 cold labelling and dispensing, compatible with all Gallium-68 generators. Features remote control operation and FDA 21 CFR Part 11 compliant data management. Launched January 2020.
  • AGLTS 2 Automatic Glove Leak Testing System Automatic glove leak testing system developed for pharmaceutical isolators in response to the requirements of EU GMP Annex 1. Officially presented at Interphex in April 2023.
  • ZEROC RTP Integrity Verification System

Quantifiable outcome

  • 140+ KARL100 installations worldwide
  • +4 more outcomes

Companies that use Tema Sinergie

Customer profile

Named customers14 records

Segments4 records

Ideal customer profiles3 records

Tema Sinergie technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

Tema Sinergie partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • Acrux Radiopharma ConsultingcoreChannel Partner/ Reseller/ Distributor · 1 May 2023Strategic partnership to provide solutions and post-sale services dedicated to the Chilean nuclear medicine market. Acrux provides specialized radiopharma consulting services.
  • ATS ElektronikminorChannel Partner/ Reseller/ Distributor · 1 September 2022ATS Elektronik is the new partner of Tema Sinergie in Turkey for the Barrier Isolation Technology business unit.
  • EnvopackminorChannel Partner/ Reseller/ Distributor · 1 August 2022Envopack c.a. is the exclusive partner of Barrier Isolation Technology business unit for Venezuela and Dominican Republic.
  • Be.Integral International DistributioncoreChannel Partner/ Reseller/ Distributor · 1 June 2022Be.Integral International Distribution is the new technical-commercial partner in Germany for increasingly capillary presence on European territory.
  • AMERICAN FARMAGRUP S.A.S.coreChannel Partner/ Reseller/ Distributor · 7 May 2022New partner for Barrier Isolation Technology for Colombia, Peru, Ecuador, Panama, and Honduras with over 35 years of activity in the pharmaceutical sector. Based in Bogota, Colombia.
  • STEQ AmericacoreChannel Partner/ Reseller/ Distributor · 1 March 2022STEQ America is the new partner for Barrier Isolation Technology business unit for the North American market with nearly 20 years of market experience representing world's leading manufacturers of Pharma and Biotechnology equipment.
  • STEQ Comércio e RepresentaçõescoreChannel Partner/ Reseller/ Distributor · 1 March 2022New technical-commercial partner for Barrier Isolation Technology division for the Brazilian market with nearly 20 years of experience representing leading Pharma and Biotechnology equipment manufacturers.
  • LabLogiccoreChannel Partner/ Reseller/ Distributor · 19 November 2019Exclusive commercial agreement with LabLogic for distribution of PET and Nuclear Medicine products in the United Kingdom. LabLogic is one of the world's most respected manufacturers of instrumentation and software for Life Science, PET, Nuclear Medicine and Security sectors.
  • CyclomedicacoreChannel Partner/ Reseller/ DistributorPartner for Australian nuclear medicine market. Collaboration on Cyclowest nuclear medicine center project in Western Australia for FDG production.
  • Sonablate Corp.coreTechnology or IntegrationPowered by Sonablate Corp., Tema Sinergie distributes Sonablate HIFU - a robotic device for focal ablation of prostate using high-intensity focused ultrasound with proprietary A³ technology.
  • LabLogiccoreTechnology or IntegrationPartnership with LabLogic for customer installation support and collaboration including Royal Free London case study publication.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Tema Sinergie competitors and assessment

Company assessment

Direct peers

  • Comecer S.p.A. Italian-headquartered manufacturer of shielded cells, hot cells, and radiopharmacy equipment. Direct competitor named alongside Tema Sinergie as a top-3 global player in the radiopharmaceutical dispensing market, with overlapping product lines in PET/SPECT shielding and isolators.
  • EDAP TMS: Developer of focused ultrasound devices including Focal One for prostate tissue ablation. Direct peer in the uro-oncology HIFU segment where Tema Sinergie distributes Sonablate HIFU.
  • Trasis: Belgian developer of automated radiopharmaceutical synthesis and dispensing systems (e.g., AllInOne, Synthera). Named as the third top-3 player in radiopharmaceutical dispensing alongside Tema Sinergie and Comecer, with comparable PET/SPECT and Ga-68 product lines.
  • SKAN AG: Swiss manufacturer of aseptic and containment isolators for pharmaceutical and biotech manufacturing, including GMP-compliant barrier systems. Direct peer in the Pharma & ATMP / barrier isolation business unit.

Broad incumbents

  • Siemens Healthineers: Major medical imaging and diagnostics player with PET/CT systems and growing nuclear medicine footprint. Competes indirectly through end-to-end imaging suite sales that bundle radiopharmacy workflow components.
  • GE HealthCare: Global medical device and imaging giant offering PET tracers, cyclotrons, and increasingly adjacent radiopharmacy workflow solutions. As a broad incumbent, it competes at the system level and could expand into shielded-equipment categories.
  • Cytiva (Danaher): Global bioprocessing and aseptic manufacturing equipment provider. Competes with Tema Sinergie's pharmaceutical isolation business through broader aseptic filling and containment portfolios.
  • Getinge (Getinge Life Science): Global provider of sterilizers, isolators, and GMP process equipment for pharmaceutical manufacturing. Competes with Tema Sinergie's Pharma & ATMP division as a broad incumbent offering integrated aseptic processing solutions.
  • Curium Pharma: World's largest nuclear medicine company, supplying SPECT/PET diagnostic tracers and therapeutic radiopharmaceuticals. Comparable as a downstream customer for shielded dispensing systems and as a potential in-house equipment competitor.

Others

  • Sonablate Corp. Manufacturer of Sonablate HIFU high-intensity focused ultrasound device for prostate ablation. Technology partner of Tema Sinergie rather than a direct competitor, but represents an upstream relationship that mirrors peer dynamics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights6 records

Customer concentration

Tema Sinergie social profiles

Digital presence

Tema Sinergie financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tema Sinergie leadership team

Management profile

Number of profiles

Profiles5 records

Tema Sinergie subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Tema Sinergie funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tema Sinergie M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tema Sinergie

What does Tema Sinergie do?

Tema Sinergie designs, manufactures, and services specialized medical and pharmaceutical equipment across four business units: (1) Radiopharma & Nuclear Medicine — automated radiopharmaceutical dispensing systems, shielded hot cells, and synthesis modules for PET/SPECT applications; (2) Pharma & ATMP — GMP-compliant barrier isolation systems for aseptic processing and containment in pharmaceutical and biotechnology manufacturing; (3) Radiation Oncology & Medical Imaging — distribution of advanced treatment devices including Sonablate HIFU for prostate ablation and SpaceOAR hydrogel; (4) Uro-Oncology — minimally invasive solutions for cancer diagnosis and treatment.

Is Tema Sinergie a public or private company?

Tema Sinergie is a private company. It is classified as private equity controlled and is currently operating.

When was Tema Sinergie founded?

Tema Sinergie was founded in 1985. It employs 101 to 250 people.

Where is Tema Sinergie based?

Tema Sinergie is headquartered in Faenza, Italy, in the Europe region.

How does Tema Sinergie make money?

Four revenue lines are on record. Hardware Sales - Radiopharmacy Equipment is the primary driver. The others are hardware Sales - Pharmaceutical Isolation Systems, hardware Sales - Radiation Oncology Equipment and professional Services.

Who are Tema Sinergie's main competitors?

Direct peers on record are Comecer S.p.A., EDAP TMS, Trasis and SKAN AG. Broad incumbents are Siemens Healthineers, GE HealthCare, Cytiva (Danaher), Getinge (Getinge Life Science) and Curium Pharma. Sonablate Corp. is listed as an others.

Does Tema Sinergie have an API?

No public API is recorded for Tema Sinergie.

What industry is Tema Sinergie in?

Tema Sinergie's product category is Nuclear Medicine and Pharmaceutical Isolation Equipment. Its primary akta.pro industry code is HLAIAGAE, Radiopharmacy Compounding & Dispensing (Hospital/Commercial), with a secondary code of HLAIAGAC, Theranostic Radiopharmaceutical Platforms (Paired Dx/Tx). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MorningstarGlobal Nuclear Medicine Shielded Equipment Market | 8.2% CAGR Growth Trajectory | Radiopharmaceutical Expansion, Safety Compliance Drive Demand | Comecer, Tema Sinergie, Trasis Lead Advanced ShieldingFuture Market Insights released an analysis projecting the global nuclear medicine shielded equipment market to grow from USD 137.8 million in 2025 to USD 303.1 million by 2035, representing an 8.2% CAGR over the forecast period. The market growth is being driven by the rapid expansion of radiopharmaceutical therapies, increasing nuclear medicine procedures, and stringent radiation safety regulations, with fully automatic systems (66.1%) and pharmaceutical applications (44.7%) leading market segments.Market Research & Business IntelligenceRadiopharmaceutical Dispensing System MarketThe global radiopharmaceutical dispensing system market is projected to grow from USD 111.2 million in 2025 to USD 251.4 million by 2035, at a CAGR of 8.5%, driven by increasing demand for nuclear medicine diagnostic and therapeutic procedures worldwide. Fully automatic dispensing systems dominate with a 58.0% market share, while pharmaceutical applications lead the segment with 47.0% share. Key players in the market include Comecer S.p.A., Tema Sinergie, Trasis, Norer Shield Medical, and Mirion, with the top three companies controlling approximately 52-58% of global market share.TemasinergieRABS and Plant Retrofitting: Compliance with GMP Annex 1Tema Sinergie promotes its RABS systems as a cost-effective and efficient alternative to isolators for pharmaceutical manufacturers retrofitting existing plants to comply with the new GMP Annex 1 contamination control regulations. The article outlines a technical approach involving process analysis, CFD simulation, and design modifications to ensure reliable containment without significant design complications.The-europeanNew breast cancer radiotherapy technology launches in EuropeTema Sinergie SpA has launched GammaPod, a new technology for delivering high-dose, targeted radiotherapy for early-stage breast cancer in Europe. The first installation of GammaPod took place at the Santa Maria della Misericordia Hospital in Udine, and the company plans to expand access to this technology across the continent. GammaPod represents a significant advancement in breast cancer treatment by allowing for a higher dose of radiation to be administered in a single session.Empresas de Capital Riesgo en EspaCharme invests in Tema Sinergie SpACharme Capital Partners SGR S.p.A. has announced an investment in Tema Sinergie SpA, acquiring a majority stake to support the company's international expansion and product development in the nuclear medicine and biotech sectors. The transaction, facilitated by the €800 million Charme IV fund, is expected to close by the end of the year under standard conditions. This partnership aims to leverage Charme's operational experience to accelerate Tema Sinergie's growth in theragnostic and personalized medicine markets.Born2InvestCharme Capital Buys 70% of Tema Sinergie’s Clinical SolutionsCharme Capital has acquired 70% of Tema Sinergie’s capital, a company specializing in clinical solutions, for a total enterprise value of 200 million euros. This marks the fifth investment from Charme's fourth fund, which has secured 800 million euros in commitments. Tema Sinergie plans to recruit 200 new employees and invest 15 million euros to expand its production site over the next three years.TemasinergieEntrepreneurial partnership between Charme Capital Partners SGR S.p.A. and Tema Sinergie S.p.A.Charme Capital Partners SGR S.p.A. has entered an entrepreneurial partnership with Tema Sinergie S.p.A., acquiring a majority stake in the Italian medical technology firm through its Charme IV fund. The investment aims to support Tema Sinergie's international expansion and product development in the theragnostic and biotech sectors, with closing expected by the end of the year. This transaction marks the fifth investment for the €800 million Charme IV fund.CharmecapitalpartnersCharme invests in Tema Sinergie SpAPostCharme Capital Partners SGR S.p.A. has entered a partnership to acquire a majority stake in Tema Sinergie SpA through its Charme IV fund, which manages €800 million. The transaction aims to support Tema Sinergie's international expansion and product development in the nuclear medicine and biotech pharmaceutical sectors. The deal is expected to close by the end of the year subject to standard conditions.PR NewswireEvergreen Theragnostics Expands Alpha Radiopharmaceutical Production CapabilitiesEvergreen Theragnostics is undertaking a strategic expansion at its Springfield, NJ manufacturing facility to build a GMP alpha emitter production center, scheduled to open in Q1 2022, which will support the development and manufacturing of alpha-based radiopharmaceuticals for oncology applications. The new center will handle Actinium-225, Astatine-211, Lead-212, and Thorium-227-based radiopharmaceuticals and was designed in partnership with Tema Sinergie to address the unique manufacturing challenges of alpha-emitting drugs in a full cGMP environment. This expansion positions Evergreen to offer comprehensive clinical manufacturing solutions for Targeted Alpha Therapy programs, potentially accelerating novel cancer treatments to patients.PR NewswireIl sistema di radioterapia stereotassica GammaPod per il cancro al seno ha ricevuto il marchio CEXcision Medical Systems announced that its GammaPod stereotactic radiotherapy system for breast cancer has received the CE mark, enabling sales in Europe. This regulatory approval allows the company to expand into the European market and offers patients a non-invasive treatment option delivered in five or fewer sessions. Xcision is represented in key European markets by Tema Sinergie S.p.A. and OncoMed Solutions LLC.